GlassScriptPhysician profile
Meghan Krish Patni
NPI 1093077687
$16,691.68
in general payments reported to CMS, 2019-2025
44 companies · $1,301 in 2025
The $1,301 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,454 · 2020: $2,767 · 2021: $2,067 · 2022: $2,188 · 2023: $2,853 · 2024: $3,063 · 2025: $1,301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,315 · Travel and Lodging: $821 · Education: $80.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,315.32 |
| Travel and Lodging | $820.64 |
| Education | $80.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $2,486.66 | 2020-2024 | (Br4) Coronary Undivided, (Bq9) Coronary Ivus |
| Boston Scientific Corporation | $1,833.32 | 2019-2025 | Watchman Flx, General - Catheter, General - Atherectomy |
| Cardiovascular Systems INC. | $1,701.21 | 2019-2023 | Diamondback Coronary |
| Medtronic, INC. | $1,560.54 | 2023-2025 | Onyx Frontier, Resolute Onyx, Linq II |
| Abbott Laboratories | $1,424.06 | 2019-2025 | Cardiomems, Optis, Amplatzer |
| Abiomed | $1,051.94 | 2019-2024 | Impella |
| Amgen INC. | $702.40 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $642.92 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $544.62 | 2019-2025 | Lifevest |
| Pfizer INC. | $478.38 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $475.67 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $475.07 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $418.04 | 2020-2024 | Eliquis, Camzyos |
| Irhythm Technologies, INC. | $315.38 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $274.66 | 2020-2025 | Jardiance |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $239.37 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $226.89 | 2019-2024 | Farxiga |
| Penumbra, INC. | $214.26 | 2019-2025 | Indigo System |
| Terumo Medical Corporation | $197.13 | 2019-2025 | Tr Band |
| Teleflex LLC | $177.45 | 2020-2024 | Turnpike, Guideliner |
| Cardiva Medical, INC. | $147.27 | 2024 | Cardiva Vascade 6/7f Vcs |
| Novo Nordisk INC | $141.65 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Medtronic Vascular, INC. | $140.85 | 2019 | |
| Kestra Medical Technology Services, INC. | $135.26 | 2023-2025 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $74.24 | 2019-2023 | |
| Alnylam Pharmaceuticals INC. | $71.48 | 2024-2025 | Amvuttra |
| Merck Sharp & Dohme LLC | $64.99 | 2024-2025 | Verquvo |
| Amarin Pharma, INC. | $63.81 | 2019-2021 | |
| Chiesi USA, INC. | $57.67 | 2020-2023 | Kengreal |
| Kiniksa Pharmaceuticals International, Plc | $50.36 | 2024 | Arcalyst |
| Daiichi Sankyo INC. | $46.62 | 2020-2021 | |
| Baxter Healthcare | $32.87 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Regeneron Healthcare Solutions, INC. | $30.87 | 2019 | |
| Genzyme Corporation | $25.51 | 2024 | |
| Lantheus Medical Imaging, INC. | $24.05 | 2023 | Definity |
| Heartflow, INC. | $19.33 | 2022 | |
| Edwards Lifesciences Corporation | $18.35 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.47 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $16.76 | 2023 | Arcalyst |
| Osprey Medical INC | $16.00 | 2019 | |
| Esperion Therapeutics, INC. | $15.64 | 2024 | Nexletol |
| Amryt Pharma Holdings LTD | $15.20 | 2021 | |
| Davol INC. | $13.52 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Patni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.